Okyo Pharma Ltd Stock Alpha and Beta Analysis
| OKYO Stock | USD 1.05 0.02 1.87% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as OKYO Pharma Ltd. It also helps investors analyze the systematic and unsystematic risks associated with investing in OKYO Pharma over a specified time horizon. Remember, high OKYO Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to OKYO Pharma's market risk premium analysis include:
Beta (0.18) | Alpha 0.18 | Risk 5.62 | Sharpe Ratio 0.0535 | Expected Return 0.3 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
OKYO |
OKYO Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. OKYO Pharma market risk premium is the additional return an investor will receive from holding OKYO Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in OKYO Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate OKYO Pharma's performance over market.| α | 0.18 | β | -0.18 |
OKYO Pharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of OKYO Pharma's Buy-and-hold return. Our buy-and-hold chart shows how OKYO Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.OKYO Pharma Market Price Analysis
Market price analysis indicators help investors to evaluate how OKYO Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading OKYO Pharma shares will generate the highest return on investment. By understating and applying OKYO Pharma stock market price indicators, traders can identify OKYO Pharma position entry and exit signals to maximize returns.
OKYO Pharma Return and Market Media
The median price of OKYO Pharma for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 is 1.05 with a coefficient of variation of 6.65. The daily time series for the period is distributed with a sample standard deviation of 0.07, arithmetic mean of 1.07, and mean deviation of 0.05. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | OKYO Pharma Announces Chairman Acquires Shares - Yahoo Finance | 09/10/2024 |
2 | OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain | 10/23/2024 |
3 | MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 11/15/2024 |
About OKYO Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including OKYO or other stocks. Alpha measures the amount that position in OKYO Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Net Current Asset Value | 42.89 | 38.12 | Days Payables Outstanding | 213.7K | 194.5K |
OKYO Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of OKYO Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, OKYO Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of OKYO Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of OKYO Pharma. Please utilize our Beneish M Score to check the likelihood of OKYO Pharma's management manipulating its earnings.
| 21st of August 2023 Upcoming Quarterly Report | View | |
| 31st of March 2023 Next Fiscal Quarter End | View |
Build Portfolio with OKYO Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out OKYO Pharma Backtesting, OKYO Pharma Valuation, OKYO Pharma Correlation, OKYO Pharma Hype Analysis, OKYO Pharma Volatility, OKYO Pharma History and analyze OKYO Pharma Performance. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
OKYO Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.